APOB and familial hypercholesterolemia: ApoB is the primary apolipoprotein of low-density lipoproteins (LDL), which is a target of mipomersen (KYNAMRO®),39,40 a commercialized antisense oligonucleotide for the treatment of homozygous familial hypercholesterolemia.